CXCL12 and cancer: In particular, CXCL12 was expressed to high extents (cutoff = 10.5 cells/punch in primary, cutoff = 10 cells/punch in recurrent cancer, respectively) in 32 out of 43 primary and in 29 out of 41 recurrent cancer biopsies (Table 2A, B).